Impact of Metastatic Site in Favorable-Risk Renal Cell Carcinoma Receiving Sunitinib or Pazopanib

Autor: Catalano, Martina, De Giorgi, Ugo, Bimbatti, Davide, Buti, Sebastiano, Procopio, Giuseppe, Sepe, Pierangela, Santoni, Matteo, Galli, Luca, Conca, Raffaele, Doni, Laura, Antonuzzo, Lorenzo, Roviello, Giandomenico
Zdroj: In Clinical Genitourinary Cancer April 2024 22(2):514-522
Databáze: ScienceDirect